BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23050782)

  • 1. Lactoferrin and its hydrolysate bind directly to the oleate-activated form of the lipolysis stimulated lipoprotein receptor.
    Ahmad N; Girardet JM; Akbar S; Lanhers MC; Paris C; Yen FT; Corbier C
    FEBS J; 2012 Dec; 279(23):4361-73. PubMed ID: 23050782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase.
    Stenger C; Hanse M; Pratte D; Mbala ML; Akbar S; Koziel V; Escanyé MC; Kriem B; Malaplate-Armand C; Olivier JL; Oster T; Pillot T; Yen FT
    FASEB J; 2010 Nov; 24(11):4218-28. PubMed ID: 20647547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein.
    Yen FT; Mann CJ; Guermani LM; Hannouche NF; Hubert N; Hornick CA; Bordeau VN; Agnani G; Bihain BE
    Biochemistry; 1994 Feb; 33(5):1172-80. PubMed ID: 7509190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor.
    Mann CJ; Khallou J; Chevreuil O; Troussard AA; Guermani LM; Launay K; Delplanque B; Yen FT; Bihain BE
    Biochemistry; 1995 Aug; 34(33):10421-31. PubMed ID: 7654696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice.
    Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE
    J Biol Chem; 2008 Sep; 283(37):25650-25659. PubMed ID: 18644789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver mechanisms for the elimination of lipoproteins of intestinal origin].
    Khallou J; Troussard AA; Masson M; Delplanque B; Mann CJ; André P; Yen FT; Bihain BE
    C R Seances Soc Biol Fil; 1995; 189(5):899-904. PubMed ID: 8673635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone.
    Niemeier A; Kassem M; Toedter K; Wendt D; Ruether W; Beisiegel U; Heeren J
    J Bone Miner Res; 2005 Feb; 20(2):283-93. PubMed ID: 15647823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver.
    Yen FT; Masson M; Clossais-Besnard N; André P; Grosset JM; Bougueleret L; Dumas JB; Guerassimenko O; Bihain BE
    J Biol Chem; 1999 May; 274(19):13390-8. PubMed ID: 10224102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipolysis-stimulated receptor: a newcomer on the lipoprotein research scene.
    Bihain BE; Delplanque B; Khallou J; Chevreuil O; Troussard AA; Michel L; Mann CJ; Yen FT
    Diabete Metab; 1995 Apr; 21(2):121-6. PubMed ID: 7621972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice.
    Salerno AG; Patrício PR; Berti JA; Oliveira HC
    Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
    Heeren J; Niemeier A; Merkel M; Beisiegel U
    J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance.
    Laatsch A; Merkel M; Talmud PJ; Grewal T; Beisiegel U; Heeren J
    Atherosclerosis; 2009 May; 204(1):105-11. PubMed ID: 18834984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activity.
    Giroux LM; Cohn JS; LaMarre J; Davignon J
    Atherosclerosis; 1997 Jul; 132(1):85-94. PubMed ID: 9247363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein.
    Troussard AA; Khallou J; Mann CJ; André P; Strickland DK; Bihain BE; Yen FT
    J Biol Chem; 1995 Jul; 270(29):17068-71. PubMed ID: 7615497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and free fatty acids: double trouble.
    Castro Cabezas M; Halkes CJ; Erkelens DW
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):134-42. PubMed ID: 11434190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.